SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-050142
Filing Date
2019-09-13
Accepted
2019-09-13 16:30:31
Documents
1
Period of Report
2019-09-04

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6433
  Complete submission text file 0001104659-19-050142.txt   7865
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address
Wolin Jonathan S. (Reporting) CIK: 0001787587 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36714 | Film No.: 191092893